Screening for Cancers of Other Sites: Lung, Stomach, Oral and Neuroblastoma

  • Jocelyn Chamberlain
Part of the Focus on Cancer book series (3292)


Screening has been advocated as a means of control for various other cancer sites, four of which are reviewed here. Lung cancer, although theoretically preventable, is still the commonest cancer in the developed world and is rapidly increasing in developing countries. Studies of screening, however, have led to the conclusion that it is largely ineffective due to the rapid progression of potentially fatal disease.


Lung Cancer Gastric Cancer Oral Cancer Stomach Cancer Mass Screening 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Auerbach O, Hammond EC, Garfinkel L (1979) Changes in bronchial epithelium in relation to cigarette smoking, 1955–1960 vs 1970–1977. N Engl J Med 300:381–386.PubMedCrossRefGoogle Scholar
  2. 2.
    Axell T (1987) Occurrence of leukoplakia and some other oral white lesions among 20 333 adult Swedish people. Community Dent Oral Epidemiol 15:46–51.PubMedCrossRefGoogle Scholar
  3. 3.
    Bailar JC (1984) Screening for lung cancer — where are we now? Am Rev Respir Dis 130:541–542.PubMedGoogle Scholar
  4. 4.
    Barker DJ, Coggon D, Holdsmond C, Wickham C (1990) Poor housing and high rates of stomach cancer in England and Wales. Br J Cancer 61:575–578.PubMedCrossRefGoogle Scholar
  5. 5.
    Beckwith JB, Perrin EV (1963) In-situ neuroblastomas: a contribution to the natural history of neural crest tumours. Am J Pathol 43:1089–1104.PubMedGoogle Scholar
  6. 6.
    Berlin NI, Buncher CR, Fontana RS, Frost JK, Melamed MR (1984) The National Cancer Institute Cooperative Early Lung Cancer Detection Program. Results of the initial screen (prevalence). Early lung cancer detection: introduction. Am Rev Respir Dis 130:545–549.PubMedGoogle Scholar
  7. 7.
    Bernstein ML, Leclerc JM, Bunin G et al. (1992) A population-based study of neuroblastoma incidence, survival and mortality in North America. J Clin Oncol 10:323–329.PubMedGoogle Scholar
  8. 8.
    Besscho F, Hashizuma K, Nakajo T, Kamoshita S (1991) Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children. J Pediatr 119:237–241.CrossRefGoogle Scholar
  9. 9.
    Birrer MJ, Brown PH (1992) Application of molecular genetics to the early diagnosis and screening of lung cancer. Cancer Res (Suppl) 52:2658–2664.Google Scholar
  10. 10.
    Black RJ, Sharp L, Kendrick SW (1993) Trends in cancer survival in Scotland 1968–1990. ISD Publications, Edinburgh.Google Scholar
  11. 11.
    Blot WJ, McLaughlin JK, Wynn DM et al. (1988) Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48:3282–3287.PubMedGoogle Scholar
  12. 12.
    Blot WJ (1992) Alcohol and cancer. Cancer Res 50(Suppl):2119–2123.Google Scholar
  13. 13.
    Boyle P, Macfarlane GJ, Maisonneuve P, Zheng T (1990) Epidemiology of mouth cancer in 1989: a review. J R Soc Med 83:724–730.PubMedGoogle Scholar
  14. 14.
    Boyle P, Macfarlane GJ, Scully C (1993) Oral cancer: necessity for prevention strategies. Lancet 342:1129.PubMedCrossRefGoogle Scholar
  15. 15.
    Brett GZ (1968) The value of lung cancer detection by six-monthly chest radiographs. Thorax 23:414–420.PubMedCrossRefGoogle Scholar
  16. 16.
    Brodeur GM, Hayes FA, Green AA et al. (1987) Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. Cancer Res 47:4248–4253.PubMedGoogle Scholar
  17. 17.
    Brodeur GM, Pritchard J, Berthold F et al. (1993) Revisions of the International Criteria for Neuroblastoma Diagnosis, Staging and Response to Treatment. J Clin Oncol 11:1466–1477.PubMedGoogle Scholar
  18. Cancer Research Campaign (1990) Fact Sheet 14: Oral CancerGoogle Scholar
  19. 19.
    Cancer Research Campaign (1992) Fact Sheet 11: Lung Cancer.Google Scholar
  20. 20.
    Chamberlain J (1994) Screening for neuroblastoma. A review of the evidence. J Med Screening 1:169–175.Google Scholar
  21. 21.
    Coffin F (1964) Cancer and the dental surgeon. Br Dental J 116:191–202.Google Scholar
  22. 22.
    Coldman AJ, Fryer CH, Elwood JM, Sonley MJ (1980) Neuroblastoma: influence of age at diagnosis, stage, tumour site and sex on prognosis. Cancer 46:1896–1901.PubMedCrossRefGoogle Scholar
  23. 23.
    Doll R, Peto R (1976) Mortality in relation to smoking: 20 years’ observation on British male doctors. Br Med J iv:1525–1526.CrossRefGoogle Scholar
  24. 24.
    Draper GJ, Birch JM, Bithell JF et al. (1982) Childhood cancer in Britain. Studies on medical and population subjects, No. 37. HMSO, London.Google Scholar
  25. 25.
    Ebeling K, Nischan P (1987) Screening for lung cancer — results from a case-control study. Int J Cancer 40:141–144.PubMedCrossRefGoogle Scholar
  26. 26.
    Eddy DM (1989) Screening for lung cancer. Ann Intern Med 111:232–237.PubMedGoogle Scholar
  27. 27.
    Eurogast Study Group (1993) An international association between Helicobacter pylori infection and gastric cancer. Lancet 341:1359–1362.CrossRefGoogle Scholar
  28. 28.
    Flehinger BJ, Melamed Mr, Zaman MB et al. (1984) Screening for early detection of lung cancer in New York. In: Prorok PC, Miller AB (eds) Screening for cancer. I. General principles on evaluation of screening for cancer and screening for lung, bladder and oral cancer. UICC Technical Report Series, 78, Geneva, pp 123–135.Google Scholar
  29. 29.
    Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR (1986) Lung cancer screening: The Mayo Program. J Occup Med 28:746–750.PubMedCrossRefGoogle Scholar
  30. 30.
    Fukao A, Hisamichi S, Sugawara N (1987) A case-control study on evaluating the effect of mass screening on decreasing advanced stomach cancer. J Jpn Soc Gastroenterol Mass Surv 75:112–116.Google Scholar
  31. 31.
    Goodwin CS (1993) Gastric cancer and Helicobacter pylori: the whispering killer? Lancet 342:507–508.PubMedCrossRefGoogle Scholar
  32. 32.
    Gupta PC, Mehta FS, Daftary DK et al. (1980) Incidence rates of oral cancers and natural history of oral precancerous lesions in a 10 year follow up study of Indian villages. Community Dental Oral Epidemiol 8:287–333.CrossRefGoogle Scholar
  33. 33.
    Hakama M, Pukkala E (1988) Evaluation of an immunological screening for stomach cancer. In: Chamberlain J, Miller AB (eds) Screening for gastrointestinal cancer. International Union Against Cancer. Hans Huber, Toronto, pp 71–75.Google Scholar
  34. 34.
    Hakama M, Stenman U-H, Knekt P et al. (1994) Tumour markers and screening for gastrointestinal cancer: a follow up study in Finland. J Med Screening 1:60–64.Google Scholar
  35. 35.
    Hallissey MT, Allum WH, Jewkes AJ, Ellis DJ, Fielding JWL (1990) Early detection of gastric cancer. Br Med J 301:513–515.CrossRefGoogle Scholar
  36. 36.
    Hanawa Y, Sawada T, Tsunoda A (1990) Decrease in childhood neuroblastoma death in Japan. Med Pediatr Oncol 18:472–475.PubMedCrossRefGoogle Scholar
  37. 37.
    Hayashi Y, Kanda N, Inaba T et al. (1989) Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer 63:126–132.PubMedCrossRefGoogle Scholar
  38. 38.
    Hisamichi A, Fukao A, Sugawara N et al. (1991) Evaluation of mass screening programme for stomach cancer in Japan. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (eds) Cancer Screening. International Union Against Cancer. Cambridge University Press, Cambridge, pp 357–370.Google Scholar
  39. 39.
    International Agency for Research on Cancer (1985) Tobacco habits other than smoking, betel quid and areca-nut chewing; and some related nitrosamines. IARC Monographs on the evaluation of carcinogenic risk of chemicals to humans. IARC 37, Lyon.Google Scholar
  40. 40.
    International Agency for Research on Cancer (1989) Monograph 42: alcoholic beverages. IARC, Lyon.Google Scholar
  41. 41.
    Ishimoto K, Kiyokawa N, Fujita H et al. (1990) Problems of mass screening for neuroblastoma = analysis of false negative cases. J Pediatr Surg 5:398–401.CrossRefGoogle Scholar
  42. 42.
    Johnson NW, Ranasinghe AW, Warnakulasuriya KAAS (1993) Potentially malignant lesions and conditions of the mouth and oropharynx: natural history — cellular and molecular markers of risk. Eur J Cancer 2(2):31–51.Google Scholar
  43. 43.
    Kaneko Y, Kanda N, Maseki N et al. (1990) Current urinary mass screening for catecholamine metabolities at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study. J Clin Oncol 8:2005–2013.PubMedGoogle Scholar
  44. 44.
    Knudson AG, Meadow AT (1980) Regression of neuroblastoma IVS: a genetic hypothesis. N Engl J Med 302:1254–1256.PubMedCrossRefGoogle Scholar
  45. 45.
    Kubik A, Parkin DM, Khlat M, Erban J, Polak J, Adamec M (1990) Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer 45:26–33.PubMedCrossRefGoogle Scholar
  46. 46.
    Lamay P-J (1993) Management options in potentially malignant and malignant oral epithelial lesions. Community Dental Health 10(1):53–62.Google Scholar
  47. 47.
    Lancet (1986) Oral snuff: a preventable carcinogenic hazard. Lancet i: 198–201.Google Scholar
  48. 48.
    McLoughlin JK, Gridley G, Block G et al. (1988) Dietary factors in oral and pharyngeal cancer. J Natl Cancer Inst 80:1237–1243.CrossRefGoogle Scholar
  49. 49.
    Malaowalla AM, Silverman S, Mani NJ, Bilimoria KF, Smith LW (1976) Oral cancer in 57518 industrial workers in Gujarat, India. Cancer 37:1882–1886.CrossRefGoogle Scholar
  50. 50.
    Matsumara M, Tsunoda A, Nishi T, Nishihira H, Sasaki Y (1991) Spontaneous regression of neuroblastoma detected by mass screening. Lancet 338:447–448.CrossRefGoogle Scholar
  51. 51.
    Melamed MR, Flehinger BJ, Zaman MB et al. (1984) Screening for lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 86:44–53.Google Scholar
  52. 52.
    Miller AB (1989) Vitamins, minerals and other dietary factors. In: Miller AB (ed) Diet and the aetiology of cancer. Springer-Verlag, Berlin, pp 39–54.Google Scholar
  53. 53.
    Mincer HH, Coleman SA, Hopkins KP (1972) Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia. Oral Surg Oral Med Oral Pathol 33:389–399.PubMedCrossRefGoogle Scholar
  54. 54.
    Morson BC (1955) Intestinal metaplasia of gastric mucosa. Br J Cancer 9:365–376.PubMedCrossRefGoogle Scholar
  55. 55.
    Naito H, Sasaki M, Yamashiro K et al. (1990) Improvement in prognosis of neuroblastoma through mass population screening. J Pediatr Surg 25:245–248.PubMedCrossRefGoogle Scholar
  56. 56.
    Nash FA, Morgan JM, Tomkins JG (1968) South London lung cancer study. Br Med J 2:715–721.PubMedCrossRefGoogle Scholar
  57. 57.
    Nishi M, Miyaké H, Takeda T et al. (1987) Effects of the mass screening of neuroblastoma in Sapporo City. Cancer 60:433–435.PubMedCrossRefGoogle Scholar
  58. 58.
    Nishi M, Miyake H, Takeda T, Takasugi N, Hanai J, Kawai T (1991) Mass screening for neuroblastoma and estimation of costs. Acta Paediatr Scand 80:812–817.PubMedCrossRefGoogle Scholar
  59. 59.
    Office of Population Censuses and Surveys (1993) Cancer statistics. Registrations. Series MB1 no. 20. HMSO, London.Google Scholar
  60. 60.
    Office of Population Censuses and Surveys (1993) Mortality statistics. Cause. Series DH2 no. 19. HMSO, London.Google Scholar
  61. 61.
    Oshima A, Hirata N, Ubukata T, Umeda K, Fujimoto I (1986) Evaluation of a mass screening program for stomach cancer with a case-control study design. Int J Cancer 38:829–833.PubMedCrossRefGoogle Scholar
  62. 62.
    Parker L, Craft AW, Dale G et al. (1992) Screening for neuroblastoma in the North of England. Br Med J 305:1260–1263.CrossRefGoogle Scholar
  63. 63.
    Parkin DM, Laara E, Muir CS (1988) Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41:184–197.PubMedCrossRefGoogle Scholar
  64. 64.
    Parkin DM, Stiller CA, Draper GJ et al. (1988) International incidence of childhood cancer. IARC, Scientific Publications, No. 87, Lyon, 1988.Google Scholar
  65. 65.
    Peto R (1994) Smoking and death: the past 40 years and the next 40. Br Med J 309:937–939.CrossRefGoogle Scholar
  66. 66.
    Pindborg JJ (1980) Oral cancer and precancer. John Wright and Sons Ltd, Bristol.Google Scholar
  67. 67.
    Pindborg JJ, Daftary DK, Gupta P et al. (1991) Public health aspects of oral cancer: implications for cancer prevention in the community. In: Johnson NW (ed) Risk markers for oral cancer: detection of patients and lesions at risk, Vol 2. Cambridge University Press, Cambridge, pp 380–388.Google Scholar
  68. 68.
    Pisani P, Oliver WE, Parkin DM, Alvarez N (1994) Case-control study of gastric cancer screening in Venezuela. Br J Cancer 69:1102–1105.PubMedCrossRefGoogle Scholar
  69. 69.
    Platz H, Fries R, Hudec M (1986) Prognoses of oral cavity carcinomas. Carl Hanser Verlag, Munich, pp 187.Google Scholar
  70. 70.
    Pogrel MA (1974) The dentist and oral cancer in the north east of Scotland. Br Dental J 137:15–20.CrossRefGoogle Scholar
  71. 71.
    Prorok PC, Byar DP, Smart CR, Baker SG, Connor RJ (1991) Evaluation of screening for prostate, lung and colorectal cancers: the PLC trial. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (eds) Cancer screening. Cambridge University Press, Cambridge, pp 300–321.Google Scholar
  72. 72.
    Saccomano G, Archer VE, Auerbach O, Saunders RP, Brennan LM (1974) Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 33:256–270.CrossRefGoogle Scholar
  73. 73.
    Sankila R, Hakama M (1993) Survival trends for neuroblastoma in Finland: negative reflections on screening. Eur J Cancer 29:122–123.CrossRefGoogle Scholar
  74. 74.
    Sawada T, Kidowaki T, Sakamoto I et al. (1984) Neuroblastoma: mass screening for early detection and its prognosis. Cancer 53:2731–2735.PubMedCrossRefGoogle Scholar
  75. 75.
    Sawada T, Kawakatu H, Sugimoto T (1987) Screening for neuroblastoma. Lancet ii:1204.CrossRefGoogle Scholar
  76. 76.
    Sawada T, Matsumara T, Matsuda Y, Kawakatsu H (1991) Neuroblastoma studies in Japan. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC (eds) Cancer screening. Cambridge University Press, Cambridge, pp 325–336.Google Scholar
  77. 77.
    Schnetler JFC (1992) Oral cancer diagnosis and delays in referral. Br J Oral Maxillo-facialSurg 30:210–213.CrossRefGoogle Scholar
  78. 78.
    Scully C (1993) Clinical diagnostic methods for the detection of premalignant and early malignant oral lesions. Community Dental Health 10(1):43–52.PubMedGoogle Scholar
  79. 79.
    Shafer WG (1975) Initial mismanagement and delay in diagnosis of oral cancers. J Am Dent Assoc 90:1262–1264.PubMedGoogle Scholar
  80. 80.
    Sobue T, Suzuki T, Naruke T and The Japanese Lung Cancer Screening Research Group (1992) A case-control study for evaluating lung cancer screening in Japan. Int J Cancer 50:230–237.PubMedCrossRefGoogle Scholar
  81. 81.
    Souhami R (1992) Lung cancer. Br Med J 304:1298–1301.CrossRefGoogle Scholar
  82. 82.
    Speight PM, Morgan PR (1993) The natural history and pathology of oral cancer and precancer. Community Dental Health 10(1):31–41.PubMedGoogle Scholar
  83. 83.
    Stiller CA, Bunch KJ (1990) Trends in survival for childhood cancer diagnosed 1971-85. Br J Cancer 62:806–816.PubMedCrossRefGoogle Scholar
  84. 84.
    Stiller CA (1993) Trends in neuroblastoma in Great Britain: incidence and mortality, 1971–1990. Eur J Cancer 29A:1008–1012.PubMedCrossRefGoogle Scholar
  85. 85.
    Sue-Ling HM, Johnston D, Martin IC et al. (1993) Gastric cancer: a curable disease in Britain. Br Med J 307:591–596.CrossRefGoogle Scholar
  86. 86.
    Tockman MS, Frost JK, Stitik FP et al. (1985) Screening and detection of lung cancer. In: Aisner J (ed) Lung cancer. Churchill Livingstone, New York, pp 25–29.Google Scholar
  87. 87.
    Todd J, Lader D (1991) Adult dental health, United Kingdom 1988. HMSO, London.Google Scholar
  88. 88.
    Tsukuma T, Mishima T, Oshima A (1983) Prospective study of “early” gastric cancer. Int J Cancer 31:421–426.PubMedCrossRefGoogle Scholar
  89. 89.
    Tuchman M, Lemieux B, Auray-Blais C et al. (1990) Screening for neuroblastoma at three weeks of age: methods and preliminary results from the Quebec neuroblastoma screening project. Pediatrics 86:765–773.PubMedGoogle Scholar
  90. 90.
    Tuchman M, Ramnaraine ML, Woods WG et al. (1987) Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma. Pediatrics 79:203–205.PubMedGoogle Scholar
  91. 91.
    Walter SD, Kubik A, Parkin DM, Reissigova J, Adamec M, Khlat M (1992) The natural history of lung cancer estimated from the results of a randomized trial of screening. Cancer Causes and Control 3:115–123.PubMedCrossRefGoogle Scholar
  92. 92.
    Wang B, Yanagawa H, Sakata K (1994) Gastric cancer screening programme in Japan: how to improve its implementation in the community. J Epidemiol Community Health 48:182–187.PubMedCrossRefGoogle Scholar
  93. 93.
    Warnakulasuriya S, Ekanayake A, Stjernsward J, Pindborg JJ, Sivayoham S (1988) Compliance following referral in the early detection of oral cancer and precancer in Sri Lanka. Community Dent Oral Epidemiol 16:326–329.PubMedCrossRefGoogle Scholar
  94. 94.
    Warnakulasuriya S, Pindborg JJ (1990) Reliability of oral precancer screening by primary health care workers in Sri Lanka. Comm Dental Hlth 7:73–79.Google Scholar
  95. 95.
    Weiss W (1984) Implications of tumor growth rate for the natural history of lung cancer. J Occup Med 26:345–352PubMedCrossRefGoogle Scholar
  96. 96.
    Woods WG, Lemieux B, Tuchman M (1992) Neuroblastoma represents distinct clinical-biological entities: a review and perspective from the Quebec neuroblastoma screening project. Pediatrics 89:114–118.PubMedGoogle Scholar
  97. 97.
    World Health Organization (1978) Definitions of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46:518–539.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 1996

Authors and Affiliations

  • Jocelyn Chamberlain

There are no affiliations available

Personalised recommendations